ebook Munafa Stock Market Course + Intraday & FNO calls  

       

Biolinerx (BLRX) Technical (Analysis) Reports Biolinerx ["Technical Analysis"] Reports -USA Stock Exchange MunafaSutra.com

Complete & easy to understand technical analysis of Biolinerx (BLRX)

Technical Analysis Report for USA stock BLRX Biolinerx. Dated: 03 Mar 2026 Updated Daily. Stock trades under Health Care Deals in Major Pharmaceuticals in USA stock exchange

If you are looking for Tomorrow's Movement Predictions for USA stock BLRX Biolinerx then click here. or read Experts views on Biolinerx or Forecast & share price targets of Biolinerx

Biolinerx Opened at 2.87 and Closed at: 2.81, which is -1.78% of previous session's close. It moved within a range of 2.80 and 2.94
The session was a Bearish session with an average volume of 7000, which is -41.43% of previous session's volumes.

  • The stock has fallen, and its short term trend is also negative and in a downtrend.

Support for tomorrow is 2.74 and resistance for tomorrow is 2.88
These support and resistance points are valid for the first 5-15 minutes charts

Above are simple pivot point calculations. For a list of much stronger support and resistance levels click here. These are way more stronger support and resistance levels, and mark trend reversals and are Support & Resistance levels recommended by experts.

Support for tomorrow's hourly charts is 2.76, 2.71 resistance for tomorrow's hourly charts is 2.9, 2.99

10 Day SMA for Biolinerx (BLRX) is 2.84 and stock is trading below these levels. This is not a good sign for its short term trend

20 Day SMA for Biolinerx (BLRX) is 2.9 and the stock is trading below these levels. This is not a good sign for its mid term trend

50 Day SMA for Biolinerx (BLRX) is 2.92 and the stock is trading below these levels. This is not a good sign for its mid to long term trend

100 Day SMA is 3.19 and the stock is trading below these levels. This is not a good sign for its long term trend

200 Day SMA Biolinerx is 3.66 and stock is trading below these levels. This is not a good sign for its long term trend

20 DMA of Biolinerx is at 2.9 and 200 DMA is at 3.66, while 50 DMA and 100 DMA are at 2.92 and 3.19 respectively

Biolinerx (BLRX) moving average of 20 SMA is at 2.9 and 20 EMA is at 2.88

Biolinerx (BLRX) moving average of 50 SMA is at 2.92 and 50 EMA is at 2.97

Biolinerx (BLRX) moving average of 100 SMA is at 3.19 and 100 EMA is at 3.11

Biolinerx (BLRX) moving average of 200 SMA is at 3.66 and 200 EMA is at 3.24

Msa Safety has performed better than Biolinerx in short term. You could have earned much better returns by investing in Msa Safety, about 12.21% more returns!

Medtronic Plc has performed better than Biolinerx in short term. You could have earned much better returns by investing in Medtronic Plc, about 3.43% more returns!

Mckesson Corporation has performed better than Biolinerx in short term. You could have earned much better returns by investing in Mckesson Corporation, about 29.6% more returns!

Sol Gel has performed better than Biolinerx in short term. You could have earned much better returns by investing in Sol Gel, about 57.02% more returns!

Scynexis Inc has performed better than Biolinerx in short term. You could have earned much better returns by investing in Scynexis Inc, about 12.64% more returns!

Biolinerx has performed better than Repligen Corporation in short term. Holding Biolinerx could be a better choice for now!

Replimune Group has performed better than Biolinerx in short term. You could have earned much better returns by investing in Replimune Group, about 10.9% more returns!

Lexicon Pharmaceuticals has performed better than Biolinerx in short term. You could have earned much better returns by investing in Lexicon Pharmaceuticals, about 35.24% more returns!

Lemaitre Vascular has performed better than Biolinerx in short term. You could have earned much better returns by investing in Lemaitre Vascular, about 32.74% more returns!

Kamada has performed better than Biolinerx in short term. You could have earned much better returns by investing in Kamada, about 18.72% more returns!

Jaguar Health has performed better than Biolinerx in short term. You could have earned much better returns by investing in Jaguar Health, about 15.37% more returns!

Inmune Bio has performed better than Biolinerx in short term. You could have earned much better returns by investing in Inmune Bio, about 0.58% more returns!

Idexx Laboratories has performed better than Biolinerx in short term. You could have earned much better returns by investing in Idexx Laboratories, about 7.32% more returns!

Biolinerx has performed better than Halozyme Therapeutics in short term. Holding Biolinerx could be a better choice for now!

Biolinerx has performed better than Fulgent Genetics in short term. Holding Biolinerx could be a better choice for now!

Eyegate Pharmaceuticals has performed better than Biolinerx in short term. You could have earned much better returns by investing in Eyegate Pharmaceuticals, about 8.83% more returns!

Denali Therapeutics has performed better than Biolinerx in short term. You could have earned much better returns by investing in Denali Therapeutics, about 2.55% more returns!

Arvinas Inc has performed better than Biolinerx in short term. You could have earned much better returns by investing in Arvinas Inc, about 8.25% more returns!

Akari Therapeutics has performed better than Biolinerx in short term. You could have earned much better returns by investing in Akari Therapeutics, about 8.47% more returns!

Biolinerx Technical analysis of indicators

Price action analysis of Biolinerx (BLRX) based on a short term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.

ADX buy sell signal for Biolinerx stock for short term is SELL. Signal strength is Weak and stock is losing momentum.

MACD generated a SELL signal for Biolinerx in short term and the sell signal is strong.

Biolinerx Stock in short term is moving inside a range for now. Please check in a day or two to for a better buy sell signal. Bears are getting stronger in this stock.

Ichimoku cloud is of red color and prices are below the red cloud Prices appear to be coming down

CCI has generated a SELL signal for Biolinerx in short term but SELL signal is weak.

RSI is generating a SELL signal in short term but selling is losing momentum.

MRSI is in negative zone. This is the SELL zone

Although the stock is in the SELL zone, but selling might be slowing down

Stock of Biolinerx is picking up selling momentum according to indicator.

Volume based indicators are showing selling momentum.

Volume Weighted Averaged Price (VWAP) for short term is 2.84 and Biolinerx BLRX stock is trading below this level. This means that stock is falling with high volumes. VWAP is falling down

People seem to be coming out and selling the Biolinerx BLRX stock. Volume based technical analysis of Biolinerx BLRX stock is negative.

Biolinerx Stock has given negative returns over a short term period. Returns for a longer term period have been negative.

Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.

Tomorrow's Predictions

You should also read Tomorrow's Movement Predictions for USA stock BLRX Biolinerx These predictions are based on various factors, are easy to understand, and upto 75% accurate!

And BLRX Experts View which covers a lot of information including buying and selling signals

BLRX future forecast & share price targets

You can also take a look at the Charts and indicator analysis here Announcements & NEWS by Biolinerx or View Candle Stick Charts here

Chart Biolinerx (BLRX)  Technical (Analysis) Reports Biolinerx [

Videos related to: Biolinerx (BLRX) Technical (Analysis) Reports Biolinerx ["Technical Analysis"] Reports -USA Stock Exchange MunafaSutra.com

Hindi Basics How To Trade In FnO Futures Options Stock Market

Hindi Video The Truth Of Stock Markets That Everyone Is Hiding From You

Biolinerx (BLRX)  Technical (Analysis) Reports Biolinerx [

 

Back to top